Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implications of fetoplacental mosaicism on cell‐free DNA testing for sex chromosome aneuploidies

12 Aug 2017

Abstract excerpt

OBJECTIVE: The unique biological behavior of sex chromosomes has implications for cell-free DNA (cfDNA) testing. Our purpose is to predict the (1) false positive/negative rates of cfDNA testing consequent to fetoplacental mosaicism for any sex chromosome aneuploidies (SCA) and (2) positive predictive value (PPV) and negative predictive values of a high-risk and low-risk cfDNA result for any SCA. METHOD: This is a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomic variations and chromosomal abnormalities
Share to Gestational Trophoblastic Disease Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28801976
DOI: 10.1002/pd.5138

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implications of fetoplacental mosaicism on cell‐free DNA testing for sex chromosome aneuploidiesPMID 28801976Read ↗

Implications of fetoplacental mosaicism on cell‐free <scp>DNA</scp> testing: a review of a common biological phenomenonSemantic proximity Read ↗

Pitfalls of prenatal diagnosis associated with mosaicismSemantic proximity Read ↗

Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?Semantic proximity Read ↗

Predicting fetoplacental mosaicism during cfDNA-based NIPTSemantic proximity Read ↗

Clinical accuracy of abnormal cell‐free fetal DNA results for the sex chromosomesSemantic proximity Read ↗

Diagnostic testing after positive results on cell free DNA screening: CVS or Amnio?Semantic proximity Read ↗

Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive casesSemantic proximity Read ↗

Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA)Semantic proximity Read ↗

The type of feto‐placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedureSemantic proximity Read ↗

Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomesSemantic proximity Read ↗

Cell‐free DNA screening and sex chromosome aneuploidiesSemantic proximity Read ↗

Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasmaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.